NovaBridge Biosciences
NBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001778016
In the last 90 days, NovaBridge Biosciences insiders filed 0 open-market purchases and 4 sales; 49 institutions reported holding it in 13F filings for Q2 2026, worth $48.1M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q1 2024
Institutional positions in NovaBridge Biosciences as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −5 vs. Q4 2023
- Shares held
- 12.2M
- −148.8K (−1.2%) vs. Q4 2023
- Total value
- $22.7M
- −$767.8K (−3.3%) vs. Q4 2023
- New holders
- 6
- 11 more added
- Sold out
- 11
- 9 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 49 | $48.1M |
| Q1 2026 | 48 | $72.1M |
| Q4 2025 | 57 | $132.1M |
| Q3 2025 | 42 | $112.3M |
| Q2 2025 | 32 | $22.7M |
| Q1 2025 | 29 | $7.41M |
| Q4 2024 | 28 | $10.1M |
| Q3 2024 | 28 | $17.6M |
| Q2 2024 | 38 | $25.3M |
| Q1 2024 | 39 | $22.7M |
| Q4 2023 | 44 | $23.5M |
| Q3 2023 | 47 | $20.1M |
| Q2 2023 | 48 | $55.9M |
| Q1 2023 | 53 | $71.6M |
| Q4 2022 | 69 | $103.9M |
| Q3 2022 | 75 | $123.3M |
| Q2 2022 | 97 | $430.3M |
| Q1 2022 | 120 | $654.5M |
| Q4 2021 | 132 | $1.85B |
| Q3 2021 | 145 | $2.61B |
| Q2 2021 | 136 | $2.38B |
| Q1 2021 | 80 | $1.13B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding NovaBridge Biosciences; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 84 | $0 | 0.00% | +80+2,000.0% | Added |
| Citigroup Inc | 50 | $93 | 0.00% | 00.0% | Unchanged |
| GAMMA Investing LLC | 63 | $117 | 0.00% | 00.0% | Unchanged |
| Frazier Financial Advisors, LLC | 375 | $698 | 0.00% | +75+25.0% | Added |
| Legal & General Group Plc | 1,191 | $2.22K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,331 | $2.48K | 0.00% | −13,948−91.3% | Reduced |
| Rhumbline Advisers | 1,371 | $2.55K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,644 | $3.00K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 4,065 | $7.56K | 0.00% | +1,897+87.5% | Added |
| BlackRock Inc. | 7,923 | $14.7K | 0.00% | −92,142−92.1% | Reduced |
| Morgan Stanley | 10,109 | $18.8K | 0.00% | −506,587−98.0% | Reduced |
| Bank of America Corp | 18,857 | $35.1K | 0.00% | −23,574−55.6% | Reduced |
| Atom Investors LP | 29,612 | $55.1K | 0.01% | +29,612 | New |
| Donald L. Hagan, LLC | 30,000 | $55.8K | 0.03% | 00.0% | Unchanged |
| XTX Topco Ltd | 30,485 | $56.7K | 0.01% | −5,466−15.2% | Reduced |
| Mariner, LLC | 31,535 | $58.7K | 0.00% | +17,937+131.9% | Added |
| Geode Capital Management, LLC | 34,347 | $63.9K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 38,552 | $71.7K | 0.00% | −134,512−77.7% | Reduced |
| Dimensional Fund Advisors LP | 60,407 | $112.4K | 0.00% | +24,284+67.2% | Added |
| Renaissance Technologies LLC | 63,800 | $119.0K | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 71,088 | $132.2K | 0.00% | +71,088 | New |
| Alberta Investment Management Corp | 74,723 | $139.0K | 0.00% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 81,262 | $151.1K | 0.01% | +47,712+142.2% | Added |
| Goldman Sachs Group Inc | 84,941 | $158.0K | 0.00% | −60,254−41.5% | Reduced |
| Invesco Ltd. | 85,144 | $158.4K | 0.00% | +65,381+330.8% | Added |
| Millennium Management LLC | 93,508 | $173.9K | 0.00% | −97,793−51.1% | Reduced |
| State Street Corp | 110,373 | $205.3K | 0.00% | +8,674+8.5% | Added |
| Man Group plc | 134,977 | $251.1K | 0.00% | +24,353+22.0% | Added |
| Catalyst Funds Management Pty Ltd | 146,290 | $272.1K | 0.08% | +146,290 | New |
| Standard Life Aberdeen plc | 162,580 | $302.4K | 0.00% | 00.0% | Unchanged |
| EDBI Pte Ltd | 222,136 | $413.2K | 0.46% | 00.0% | Unchanged |
| Exome Asset Management LLC | 325,762 | $605.9K | 0.52% | +325,762 | New |
| Boothbay Fund Management, LLC | 378,269 | $703.6K | 0.02% | +378,269 | New |
| Gsa Capital Partners LLP | 432,621 | $805.0K | 0.06% | −105,498−19.6% | Reduced |
| Temasek Holdings (Private) Ltd | 566,650 | $1.05M | 0.01% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 575,580 | $1.07M | 0.00% | +679+0.1% | Added |
| Two Sigma Advisers, LP | 617,100 | $1.15M | 0.00% | +58,400+10.5% | Added |
| Caligan Partners LP | 756,538 | $1.41M | 0.37% | +756,538 | New |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 6,909,220 | $12.9M | 0.28% | 00.0% | Unchanged |
| Canada Pension Plan Investment Board | 0 | $0 | 0.00% | −313,600−100.0% | Sold out |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −310,499−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −155,572−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −99,295−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −74,029−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −29,365−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −24,608−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −23,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −17,354−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,073−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −7,698−100.0% | Sold out |